Currently, it refers to the effective peptide for the treatment of hypoglycemia. 11. Claim 1: a compound having the following characteristics: it includes Tyr ser Gln Gly thr Phe thr ser ASP Tyr ser Lys Tyr Leu ASP (AIB) - Lys Lys ala Gln Glu Phe Val Glu Trp Leu Lys thr Gly Pro ser Gly ala Pro Pro Pro Pro Lys nhsec (No. 22832);La presente se refiere a un péptido útil en el tratamiento de hipoglicemia. Reivindicación 1: Un compuesto caracterizado porque comprende la secuencia de aminoácido de Tyr-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-(Aib)-Lys-Lys-Ala-Gln-Glu-Phe-Val-Glu-Trp-Leu-Leu-Lys-Thr-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Lys-Ser-Lys-NH₂ (SEC ID Nº 2).